Back

Increase of HF re-admission rate by chronic administration of tolvaptan for the tolvaptan non-responders.

23 May 2016 (08:30 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 3 - Diuretics and fluid status management Diuretics HFA Premium Access HEART FAILURE 2016

About the speaker

Photo
Doctor Kei Tsukamoto

Tokyo Women's Medical University, Tokyo (Japan)

9 More presentations in this session

Presentation thumbnail
Doctor J. Ribeiro (Porto, PT)
Abstract Slides
Presentation thumbnail
Presentation thumbnail
Doctor T. Ando (Nishinomiya, JP)
Abstract
Presentation thumbnail
Doctor C. Mina (Palermo, IT)
Abstract Slides
Presentation thumbnail
Doctor K. Adams Jr (Chapel Hill, US)
Abstract

Access the full session

Session thumbnail
Poster Session 3 - Diuretics and fluid status management

The Event

Event poster

HEART FAILURE 2016

23 May 2016 08:30 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources